
Results
62
Stocks where the price continues to rise after more than a year of consistent gains.
62 companies
Pharmaron Beijing
Market Cap: CN¥82.9b
Operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.
300759
CN¥49.80
7D
25.8%
1Y
65.1%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$65.7b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$70.25
7D
26.5%
1Y
186.0%
10x Genomics
Market Cap: US$7.5b
Develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.
TXG
US$58.15
7D
27.5%
1Y
339.2%
Genscript Biotech
Market Cap: HK$56.9b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$25.98
7D
31.3%
1Y
48.5%
MGI Tech
Market Cap: CN¥29.0b
Engages in the research, development, production, and sale of instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally.
688114
CN¥70.29
7D
40.8%
1Y
3.7%
AbCellera Biologics
Market Cap: US$3.4b
Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
ABCL
US$10.97
7D
68.0%
1Y
143.8%
Harbin Pharmaceutical Group
Market Cap: CN¥22.3b
Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.
600664
CN¥8.86
7D
42.4%
1Y
127.2%
Shanghai Haoyuan Chemexpress
Market Cap: CN¥21.1b
Engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs.
688131
CN¥98.97
7D
23.1%
1Y
80.3%
GemPharmatech
Market Cap: CN¥16.7b
A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.
688046
CN¥40.95
7D
47.5%
1Y
132.7%
HitGen
Market Cap: CN¥16.0b
Operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally.
688222
CN¥39.86
7D
29.1%
1Y
78.8%
AcrobiosystemsLtd
Market Cap: CN¥14.7b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥88.21
7D
63.5%
1Y
54.1%
Sino BiologicalInc
Market Cap: CN¥14.6b
Engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally.
301047
CN¥120.00
7D
33.5%
1Y
65.2%
Shanghai Medicilon
Market Cap: CN¥14.1b
A contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally.
688202
CN¥107.35
7D
31.2%
1Y
67.2%
Shanghai InnoStar Bio-tech
Market Cap: CN¥13.4b
Provides drug research and development services in China and internationally.
688710
CN¥95.20
7D
22.2%
1Y
122.7%
Lin BioScience
Market Cap: NT$62.8b
A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.
6696
NT$881.00
7D
20.0%
1Y
447.2%
PharmaBlock Sciences (Nanjing)
Market Cap: CN¥12.8b
Provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally.
300725
CN¥54.79
7D
36.6%
1Y
14.9%
Nanjing Vazyme Biotech
Market Cap: CN¥12.6b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥24.42
7D
24.7%
1Y
25.0%
HBM Holdings
Market Cap: HK$13.7b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$15.81
7D
24.2%
1Y
36.9%
HARBIN GLORIA PHARMACEUTICALS
Market Cap: CN¥9.5b
Engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally.
002437
CN¥4.25
7D
49.6%
1Y
13.3%
Shanghai OPM Biosciences
Market Cap: CN¥9.4b
Provides cell culture media and CDMO services in China and internationally.
688293
CN¥67.53
7D
25.6%
1Y
21.0%
Anhui Wanbang Pharmaceutical TechnologyLtd
Market Cap: CN¥8.2b
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
301520
CN¥88.68
7D
76.7%
1Y
170.7%
Bide Pharmatech
Market Cap: CN¥7.3b
Engages in the research, development, production, and sale of drug molecule building blocks and scientific reagents in China.
688073
CN¥84.83
7D
65.3%
1Y
41.5%
PharmaResources (Shanghai)
Market Cap: CN¥7.0b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥39.06
7D
44.6%
1Y
30.4%
Omeros
Market Cap: US$992.3m
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.
OMER
US$17.35
7D
31.9%
1Y
321.1%
Novogene
Market Cap: CN¥6.7b
Provides genomic services and solutions in Mainland China, Hong Kong, Macau, Taiwan, and internationally.
688315
CN¥16.50
7D
24.6%
1Y
0.8%
R&G PharmaStudies
Market Cap: CN¥6.1b
Operates as a clinical trial outsourcing service provider in China and internationally.
301333
CN¥63.57
7D
25.9%
1Y
14.5%
GlaxoSmithKlineE
Market Cap: ج.م43.5b
Engages in production of pharmaceutical chemicals.
BIOC
ج.م521.01
7D
31.0%
1Y
974.7%
Gansu Longshenrongfa Pharmaceutical IndustryLTD
Market Cap: CN¥5.7b
Researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally.
300534
CN¥18.92
7D
27.0%
1Y
76.3%
Aarti Pharmalabs
Market Cap: ₹79.2b
Manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally.
AARTIPHARM
₹873.65
7D
26.2%
1Y
15.3%
Xinjiang Bai Hua Cun Pharma TechLtd
Market Cap: CN¥5.6b
Engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.
600721
CN¥14.50
7D
51.4%
1Y
83.3%
Boji Medical TechnologyLtd
Market Cap: CN¥5.5b
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
300404
CN¥14.45
7D
45.8%
1Y
33.5%
Sichuan Goldstone Asia Pharmaceutical
Market Cap: CN¥5.2b
Sichuan Goldstone Asia Pharmaceutical Inc.
300434
CN¥12.86
7D
22.2%
1Y
22.0%
Novoprotein Scientific
Market Cap: CN¥4.5b
Researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania.
688137
CN¥64.00
7D
64.4%
1Y
41.4%
Oncolys BioPharma
Market Cap: JP¥98.7b
Engages in the research, development, manufacturing, sale, and import of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the United States, and Asia.
4588
JP¥3,370.00
7D
20.4%
1Y
389.8%
OmniAb
Market Cap: US$497.2m
A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
OABI
US$3.43
7D
53.1%
1Y
71.5%
Shanghai Kai Kai Industry
Market Cap: CN¥3.2b
Engages in the wholesale and retail of pharmaceutical products in China.
600272
CN¥16.00
7D
35.7%
1Y
19.3%